Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qingyan Kong

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Hepatocellular Carcinoma|August 22, 2023
Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching AnalysisQingyan Kong, Mengshi Yi, Fei Teng, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2022
Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analysesMengshi Yi, Wei Peng, Xi Feng, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomyQingyan Kong, Jiahui Yang, Diao Kong, et al.
Critical Reviews in Oncology/Hematology|June 6, 2026
Integrating Multiple Outcomes of First-Line Immunotherapy-Based Regimens for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III TrialsGuilin Nie, Xinming Li, Yaoqun Wang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Hepatocellular Carcinoma|August 22, 2023
Sarcopenia Imperils Postoperative Long-Term Survival in HCC Patients with Metabolic Dysfunction-Associated Fatty Liver Disease: A Propensity Score Matching AnalysisQingyan Kong, Mengshi Yi, Fei Teng, et al.
Alimentary Pharmacology & Therapeutics|August 21, 2022
Extrahepatic morbidities and mortality of NAFLD: an umbrella review of meta-analysesMengshi Yi, Wei Peng, Xi Feng, et al.
Hepatobiliary Surgery and Nutrition|June 11, 2026
Impact of metabolic dysfunction-associated steatotic liver disease on long-term prognosis in hepatocellular carcinoma patients undergoing hepatectomyQingyan Kong, Jiahui Yang, Diao Kong, et al.
Critical Reviews in Oncology/Hematology|June 6, 2026
Integrating Multiple Outcomes of First-Line Immunotherapy-Based Regimens for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III TrialsGuilin Nie, Xinming Li, Yaoqun Wang, et al.
Pageof 2